VBI Vaccines shares are trading lower after the company announced an $18 million public offering and a $3 million concurrent registered direct offering.
Portfolio Pulse from Benzinga Newsdesk
VBI Vaccines has announced an $18 million public offering and a $3 million concurrent registered direct offering. This has led to a decrease in the company's share price.
July 06, 2023 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
VBI Vaccines' shares are trading lower after the company announced an $18 million public offering and a $3 million concurrent registered direct offering.
The announcement of a public offering typically leads to a decrease in the company's share price as it dilutes the value of existing shares. This is likely the reason for the drop in VBI Vaccines' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100